IACS-6274 With or Without Pembrolizumab for the Treatment of Advanced Solid Tumors
Publication date: Sep 10, 2021 This phase I trial tests the safety, side effects, and ...
Melanoma
This magazine is directed toward patients with Melanoma, their families, care givers, physicians and researchers. The content is gathered, validated, categorized, and supplied using a novel big data cyberinfrastructure technology that continually learns about Melanoma.
You may filter the results to view only the latest news, media (podcasts and videos) or scientific literature using these buttons.
-
-
IACS-6274 With or Without Pembrolizumab for the Treatment of Advanced Solid Tumors
Publication date: Sep 10, 2021 This phase I trial tests the safety, side effects, and ... -
IACS-6274 With or Without Pembrolizumab for the Treatment of Advanced Solid Tumors
Publication date: Sep 10, 2021 This phase I trial tests the safety, side effects, and ... -
IACS-6274 With or Without Pembrolizumab for the Treatment of Advanced Solid Tumors
Publication date: Sep 10, 2021 This phase I trial tests the safety, side effects, and ... -
In BRAF-Mutated Advanced Melanoma, Range of First-line Choices Brings Hope, Questions
Publication date: Sep 12, 2021 They listed 8 ongoing trials, ranging from phase 1 to ... -
In BRAF-Mutated Advanced Melanoma, Range of First-line Choices Brings Hope, Questions
Publication date: Sep 12, 2021 They listed 8 ongoing trials, ranging from phase 1 to ... -
In BRAF-Mutated Advanced Melanoma, Range of First-line Choices Brings Hope, Questions
Publication date: Sep 12, 2021 They listed 8 ongoing trials, ranging from phase 1 to ... -
In BRAF-Mutated Advanced Melanoma, Range of First-line Choices Brings Hope, Questions
Publication date: Sep 12, 2021 They listed 8 ongoing trials, ranging from phase 1 to ... -
OncoBeta initiates international EPIC-Skin study with Rhenium-SCT(R) for the treatment of Skin Cancer
Publication date: Sep 10, 2021 Since its foundation, OncoBeta has concentrated its efforts on the ... -
Melatect: A Machine Learning Model Approach For Identifying Malignant Melanoma in Skin Growths
Publication date: Sep 07, 2021 Malignant melanoma is a common skin cancer that is mostly ... -
Proposed Classification System Accurately Forecasts Mortality Risk for Cutaneous Melanoma
Publication date: Sep 09, 2021 In contrast, the nodal classification system proposed by Zumsteg et ... -
TriSalus enrolls first patient in pressure-enabled drug delivery trial for treating melanoma
Publication date: Sep 08, 2021 We are eager to advance innovative treatment options to improve ... -
TriSalus enrolls first patient in pressure-enabled drug delivery trial for treating melanoma
Publication date: Sep 08, 2021 We are eager to advance innovative treatment options to improve ... -
Sex Inequalities Persist in Cancer Clinical Trials
Publication date: Sep 08, 2021 Only systemic drug trials were included. Concepts Keywords Cancers MEK ... -
New research into melanocytes could improve treatments for melanoma
Publication date: Sep 07, 2021 Improving treatments for melanoma Through their research, the team identified ... -
Implementation of Teledermoscopy and Artificial Intelligence
Publication date: Sep 03, 2021 The study has 2 parts. Part 1 will investigate the ... -
Pembrolizumab + Infliximab for Metastatic Melanoma
Publication date: Sep 03, 2021 The purpose of this research is to test the safety ... -
A Phase I Trial of T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers
Publication date: Sep 06, 2021 Background: KK-LC-1 is a cancer germline (CG) antigen with expression ... -
A Study to Assess YH003 in Combination With Toripalimab(Anti-PD-1 mAb) Injection in Patients With Cancers
Publication date: Sep 02, 2021 A phase II, multi-center, open-label study to evaluate the safety ... -
New Insights about Melanocytes Could Lead to More Targeted Melanoma Treatments
Publication date: Sep 03, 2021 Robert Judson-Torres, PhD One of those discoveries was a new ... -
Variations of Immune Infiltrate and Cell Plasticity Markers in Treated Metastatic Melanoma Patients
Publication date: Sep 01, 2021 COLEMAN is an opened prospective monocentric non-randomized study, initiated by ...